Soleno Therapeutics, Inc.
SLNO
$33.39
-$0.37-1.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.82% | 94.31% | 7.79% | 93.78% | 71.76% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 189.97% | 162.75% | 115.30% | 267.48% | 46.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 21.07% | 107.15% | 18.42% | 104.28% | 71.51% |
|
|
|||||
| Total Current Assets | 21.07% | 107.15% | 18.42% | 104.28% | 71.51% |
| Net Property, Plant & Equipment | -20.38% | -22.71% | 805.92% | 660.55% | 612.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -28.57% | -26.66% | -25.01% | -23.54% | -22.22% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 96.39% | 0.00% | 0.00% | -49.70% | -49.70% |
| Total Assets | 70.36% | 102.18% | 9.26% | 88.40% | 83.17% |
|
|
|||||
| Total Accounts Payable | 40.00% | 30.47% | 67.28% | -31.65% | 182.06% |
| Total Accrued Expenses | 197.91% | 370.10% | 112.84% | 80.17% | 43.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 38.02% | 55.58% | 128.38% | 92.58% | 92.67% |
| Total Finance Division Other Current Liabilities | -- | -96.55% | 389.52% | 106.95% | -- |
| Total Other Current Liabilities | -- | -96.55% | 389.52% | 106.95% | -- |
| Total Current Liabilities | 227.32% | 122.25% | 128.89% | 16.84% | 62.95% |
|
|
|||||
| Total Current Liabilities | 227.32% | 122.25% | 128.89% | 16.84% | 62.95% |
| Long-Term Debt | 0.07% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.55% | -18.17% | -- | 6,281.08% | 1,801.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -96.46% | 37.38% | 34.49% | 49.82% | 28.25% |
| Total Liabilities | 32.44% | 228.33% | 294.31% | 237.24% | 270.34% |
|
|
|||||
| Common Stock & APIC | 26.41% | 46.83% | 23.35% | 64.98% | 60.63% |
| Retained Earnings | 4.62% | -19.80% | -56.65% | -66.56% | -63.62% |
| Treasury Stock & Other | 14.96% | -59.78% | 155.56% | 313.21% | -- |
| Total Common Equity | 83.64% | 86.93% | -14.47% | 61.98% | 55.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 83.64% | 86.93% | -14.47% | 61.98% | 55.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 83.64% | 86.93% | -14.47% | 61.98% | 55.62% |
|
|
|||||